Advertisement

Picture [iito] Männer Ballett 650x80px
Document › Details

CLC bio A/S. (4/9/13). "Press Release: IBM and CLC bio Deliver Combined Turnkey Genomics Sequencing Analytics Solution". Boston, MA.

Organisations Organisation CLC bio A/S
  Today Qiagen Aarhus A/S
  Group Qiagen (Group)
  Organisation 2 IBM Corporation (NYSE: IBM)
  Group IBM (Group)
Products Product CLC Genomics Workbench
  Product 2 server
Index term Index term CLC bio–IBM: bioinformatics, 201304 collab product integration of IBM hardware + CLC Genomics Server s/w + Workbench s/w for sequencing analytics
Persons Person Landry-Lane, Janis (IBM 201304 Director World-wide Deep Computing)
  Person 2 Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations)
     


Today at the Bio-IT World conference in Boston, IBM and CLC bio announced a combined turnkey next generation sequencing data analytics solution. The combined platform is a scalable end-to-end solution that integrates a computing cluster build on advanced IBM hardware, CLC Genomics Server software for large-scale genomics sequencing data analysis, and CLC Genomics Workbench client software for analyzing, comparing, and visualizing high-throughput sequencing data.

"It is imperative that we serve our customers with a platform that is easy to deploy and support, delivering the power to perform their next generation sequencing workload. Molecular biologists and clinicians need these tools to realize the promise of personalized medicine. We are privileged to work with CLC bio to deliver this powerful turnkey next generation sequencing data analysis solution."
Janis Landry-Lane, Director of World-wide Deep Computing at IBM

"By combining our world-leading bioinformatics software with IBM's excellent hardware and many years of expertise in setting up and supporting eloborate IT systems, we're delivering a powerful turnkey analysis platform, which will enable institutions and scientists to handle the demands of high-throughput sequencing data analysis."
Director of Global Partner Relations at CLC bio, Mikael Flensborg

The cluster compute nodes are IBM System x® 3550 M4 rack servers powered by Intel® Xeon® E5-2650 processors. The nodes are connected to an IBM Storwize® V7000 Unified network attached storage system, which consolidates block and file workloads. Storwize V7000 Unified systems support file data storage using the IBM General Parallel File System (GPFS™). GPFS has the leading file system performance and is utilized in the world's largest HPC installations. With GPFS, CLC bio software is leveraging a shared-disk file management solution that provides fast, reliable access to NGS data for optimizing performance. The turnkey analysis platform comes in three different configurations, ranging from 48 CPU cores and 192 GBs of memory to 192 CPU cores and 768 GBs of memory, depending on the analysis requirements of the individual customer.

More on the turnkey genomics sequencing analytics solution

Read the full specifications and select benchmarks on the IBM and CLC bio turnkey genomics sequencing analytics solution here [ http://www-148.ibm.com/bin/newsletter/tool/landingPage.cgi?lpId=6155 ]


About CLC bio
http://www.clcbio.com/about

Contact CLC bio
Lasse Görlitz, VP of Communications
Tel: +1 (617) 765 0687
E-mail: lgoerlitz@clcbio.com

   
Record changed: 2016-01-10

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Qiagen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Made Without Love 650x80px




» top